8-K: ModivCare Reports Q1 2024 Results, Maintains Full-Year Guidance Amid Strategic Transformation

ModivCare's first quarter 2024 results show a 3.3% revenue increase year-over-year, with a net loss of $22.3 million, while maintaining its full-year guidance.

Summary

• ModivCare reported a service revenue of $684.5 million for the first quarter of 2024, a 3.3% increase compared to the same period in 2023.
• The company experienced a net loss of $22.3 million, or $1.57 per diluted common share, which is a larger loss than the $4.0 million loss in Q1 2023.
• Adjusted EBITDA for the quarter was $32.1 million, with an adjusted net loss of $1.2 million, or $0.09 per diluted common share.
• Cash provided by operating activities was $9.6 million, and free cash flow was $1.7 million.
• ModivCare won $171.2 million in total contract value (TCV) for Non-Emergency Medical Transportation (NEMT), with $36.4 million in annual contract value (ACV).
• The company is maintaining its full-year 2024 revenue guidance of $2.7 billion to $2.9 billion and adjusted EBITDA guidance of $190 million to $210 million.
• ModivCare expects to exit the fourth quarter of 2024 with a run-rate adjusted EBITDA of $220 million to $230 million.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the company reported a net loss, it is maintaining its full-year guidance and making progress on strategic initiatives. The focus on refinancing debt and cost savings is also positive, but the increased loss and decreased EBITDA temper the overall sentiment.

Positives

• Revenue increased by 3.3% year-over-year, indicating growth in the business.
• The company won significant new NEMT contracts, totaling $171.2 million in TCV.
• Digital integration and technology enhancements are expected to yield at least $34 million in cost savings.
• The company is actively working on refinancing its 2025 senior unsecured notes.
• ModivCare is maintaining its full-year guidance, showing confidence in its performance.
• Cash flow from operations improved significantly compared to the same quarter last year, moving from a $2.7 million loss to a $9.6 million gain.

Negatives

• The company reported a net loss of $22.3 million, a significant increase from the $4.0 million loss in the same quarter last year.
• Adjusted EBITDA decreased to $32.1 million from $50.2 million in the first quarter of 2023.
• Operating expenses increased by 4.9%, primarily due to higher service expenses.
• Adjusted net loss was $1.2 million, compared to an adjusted net income of $20.2 million in the first quarter of 2023.
• The operating loss was $3.4 million, compared to an operating income of $8.1 million in the first quarter of 2023.

Risks

• The company faces risks related to government and private insurance program funding reductions.
• There are risks associated with the implementation of alternative payment models.
• The company is exposed to potential cost containment initiatives by payors.
• Inadequacies or breaches in information technology systems pose a risk.
• The company is subject to risks related to changes in relationships with payors.
• There are risks associated with delays in collection or non-collection of accounts receivable.
• The company faces risks related to general economic conditions, including inflation and labor shortages.
• There are risks related to the company's substantial indebtedness and ability to service it.
• The company is exposed to risks related to the competitive nature of the remote patient monitoring industry.
• The company is subject to risks related to regulatory changes and compliance.

Future Outlook

ModivCare maintains its full-year 2024 revenue and adjusted EBITDA guidance and expects to exit the fourth quarter of 2024 with a run-rate adjusted EBITDA of $220 million to $230 million. The company is also focused on refinancing its 2025 senior unsecured notes.

Management Comments

• We are pleased to report first quarter 2024 results in-line with our previously announced guidance as revenue increased 3% year-over-year and adjusted EBITDA was $32 million.
• We made significant progress in our strategic transformation to optimize the Company's best-scaled supportive care services platform.
• We are confident in our path to exit the fourth quarter of 2024 with expected run-rate adjusted EBITDA of $220 million to $230 million.
• I am pleased to report that this process is well underway, and we are focused on completing it expeditiously while also optimizing for the best possible outcome.
• I want to reiterate our unwavering commitment to enhance shareholder value through any avenue available to the Company.

Industry Context

ModivCare operates in the healthcare services industry, providing non-emergency medical transportation, personal care services, and remote patient monitoring. The company's focus on integrated supportive care solutions aligns with the broader industry trend of addressing social determinants of health. The company's performance is influenced by factors such as government funding, reimbursement rates, and competition within these sectors.

Comparison to Industry Standards

• ModivCare's revenue growth of 3.3% is moderate compared to some high-growth technology-enabled healthcare companies, but it is in line with expectations for a company of its size and maturity.
• The adjusted EBITDA margin of 4.7% is lower than some of its peers in the healthcare services sector, such as companies focused on higher-margin services like telehealth or specialized care management.
• Companies like LogistiCare (now part of Carelon) and Access2Care are direct competitors in the NEMT space, and their financial performance and contract wins would be relevant benchmarks.
• In the personal care services sector, companies like Addus HomeCare and LHC Group are key comparators, and their growth rates and margins would be relevant for comparison.
• For remote patient monitoring, companies like Teladoc Health and Livongo (now part of Teladoc) are industry leaders, and their performance metrics would be relevant for comparison, although ModivCare's RPM segment is smaller in scale.

Stakeholder Impact

• Shareholders may be concerned about the increased net loss but encouraged by the maintained guidance and strategic initiatives.
• Employees may be affected by the ongoing strategic transformation and cost savings initiatives.
• Customers and payors may benefit from the company's focus on improving health outcomes and cost management.
• Suppliers and creditors may be impacted by the company's financial performance and debt refinancing efforts.

Next Steps

• The company will hold a conference call on May 3, 2024, to discuss the financial results.
• ModivCare will continue to focus on its strategic transformation and cost savings initiatives.
• The company will prioritize the refinancing of its 2025 senior unsecured notes.
• ModivCare will continue to implement new NEMT contracts won in the first quarter.

Key Dates

Keywords

ModivCare, NEMT, Healthcare Services, EBITDA, Financial Results, Revenue, Personal Care Services, Remote Patient Monitoring, Guidance, Cost Savings